Danaher Q1 Earnings Beat Estimates, Life Sciences Sales Up Y/Y

DHR beats Q1 EPS estimates and lifts 2026 outlook, but revenues miss as Diagnostics lags while bioprocessing strength and Masimo deal shape growth plans.